Filtricine (Series A(+))
Funding Details
Date Award
May 13, 2024
Vertical
Biopharma
Company Info
Founders
Grace Yang, Jimmy Wang, Xiyan Li
Market
Human Health
Location
United States
Company Description

Filtricine, Inc. is a pre-clinical-stage therapeutic company. For cancer patients who want effective, safe, and long-lasting treatment, Filtricine is developing a drug-free cancer therapy based on nutrient deprivation. By precisely taking away the nutrients that are necessary only for cancer cells, the therapy kills only the cancer—not the patient.